02.09.19: Not intended for U.S. and UK Media - New guidelines from the European Society of Cardiology (ESC):
Xarelto™ 2.5 mg plus aspirin recommended for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromesClinical practice guidelines from the European Society of Cardiology (ESC) recommend Xarelto vascular dose (2.5 mg twice daily) plus aspirin low dose once daily in the management of patients with chronic coronary syndromes (CCS) as well as for patients with diabetes and lower extremity arterial disease / New guidelines include a change in nomenclature from 'stable coronary artery disease' to 'chronic coronary syndromes' to better reflect the continuous high risk of heart attacks, str...
Source: Bayer IR Newsfeed: Events - September 2, 2019 Category: Pharmaceuticals Source Type: news
02.09.19: Bayer completes sale of iconic Coppertone™ brand to Beiersdorf
Bayer completes sale of iconic Coppertone™ brand to BeiersdorfDivestiture enables Bayer to focus on core OTC businessmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - September 1, 2019 Category: Pharmaceuticals Source Type: news
20.08.19: Bayer to sell its Animal Health business unit to Elanco
for 7.6 billion U.S. dollars
Bayer to sell its Animal Health business unit to Elanco
for 7.6 billion U.S. dollarsExit of Animal Health business completes the series of portfolio measures initiated by Bayer in November 2018 ahead of announced schedule / Enhances Bayer's focus as a global leader in life sciences mehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 20, 2019 Category: Pharmaceuticals Source Type: news
08.08.19: Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Bayer acquires BlueRock Therapeutics to build leading position in cell therapyImplied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer / Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson's disease expected later this year / BlueRock Therapeutics to continue to operate as an independent companymehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 8, 2019 Category: Pharmaceuticals Source Type: news
27.08.19: Commerzbank Sector Conference, Frankfurt, Germany
Commerzbank Sector Conference, Frankfurt, GermanyLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
05.09.19: Societe Generale European Angle Conference, Brussels, Belgium
Societe Generale European Angle Conference, Brussels, BelgiumLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
10.09.19: Credit Suisse Annual Basic Materials Conference, New York, U.S.A.
Credit Suisse Annual Basic Materials Conference, New York, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
16.09.19: Deutsche Bank German Corporate Conference, San Francisco, U.S.A.
Deutsche Bank German Corporate Conference, San Francisco, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
19.09.19: Bank of America Merrill Lynch Global Healthcare Conference, London, UK
Bank of America Merrill Lynch Global Healthcare Conference, London, UKLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
25.09.19: Goldman Sachs and Berenberg German Corporate Conference, Munich, Germany
Goldman Sachs and Berenberg German Corporate Conference, Munich, GermanyLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
26.09.19: JP Morgan Investor Forum, Milan, Italy
JP Morgan Investor Forum, Milan, ItalyLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
26.09.19: Bernstein Strategic Decision Conference, London, UK
Bernstein Strategic Decision Conference, London, UKLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
27.02.20: 2019 Annual Report
2019 Annual ReportLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
28.04.20: Annual Stockholders' Meeting 2020
Annual Stockholders' Meeting 2020Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
06.08.19: Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructure and Real Assets
Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructure and Real AssetsCurrenta valued with an attractive enterprise value of EUR 3.5 billion (100%)mehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 7, 2019 Category: Pharmaceuticals Source Type: news
